Literature DB >> 18538752

Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis.

Nicolaas E Aerts1, Evelyne J Dombrecht, Didier G Ebo, Chris H Bridts, Wim J Stevens, Luc S De Clerck.   

Abstract

Most cell surface markers for CD4(+)CD25(+) regulatory T cells (Tregs) are also expressed by activated non-regulatory T cells. Recently, CD127 down-regulation was found to identify functional Tregs in healthy individuals, but there are no data from patients with inflammatory conditions. We examined peripheral blood mononuclear cells (PBMC) from rheumatoid arthritis patients with active inflammation and from healthy controls, and found that CD4(+) T cells contained an equal proportion of CD25(+)CD127(-)/low cells in both groups. In patients, not all these cells expressed intracellular FOXP3. Upon activation by anti-CD3/anti-CD28, PBMC rapidly down-regulated CD127, while FOXP3 up-regulation was transitory and occurred in fewer cells. The activated cells were not anergic to restimulation and had no suppressive effects. The distinct kinetics indicate that the FOXP3(-)CD127(-)/low cells in rheumatoid arthritis patients most likely represent activated non-regulatory T cells. This complicates the use of CD127 for identification of Tregs in inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538752     DOI: 10.1016/j.cellimm.2008.04.008

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  23 in total

Review 1.  Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Int Immunopharmacol       Date:  2011-05-31       Impact factor: 4.932

Review 2.  Human regulatory T cells in autoimmune diseases.

Authors:  Gregory L Cvetanovich; David A Hafler
Journal:  Curr Opin Immunol       Date:  2010-09-24       Impact factor: 7.486

3.  Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients.

Authors:  T Akimova; B M Kamath; J W Goebel; K E C Meyers; E B Rand; A Hawkins; M H Levine; J C Bucuvalas; W W Hancock
Journal:  Am J Transplant       Date:  2012-09-20       Impact factor: 8.086

Review 4.  FOXP3+ regulatory T cells in the human immune system.

Authors:  Shimon Sakaguchi; Makoto Miyara; Cristina M Costantino; David A Hafler
Journal:  Nat Rev Immunol       Date:  2010-06-18       Impact factor: 53.106

5.  The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease.

Authors:  S Jia; C Li; G Wang; J Yang; Y Zu
Journal:  Clin Exp Immunol       Date:  2010-08-16       Impact factor: 4.330

6.  Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations.

Authors:  Q Zhou; J Yan; P Putheti; Y Wu; X Sun; V Toxavidis; J Tigges; N Kassam; K Enjyoji; S C Robson; T B Strom; W Gao
Journal:  Am J Transplant       Date:  2009-07-28       Impact factor: 8.086

Review 7.  Disrupted regulatory T cell homeostasis in inflammatory bowel diseases.

Authors:  Christophe Pedros; Fanny Duguet; Abdelhadi Saoudi; Marianne Chabod
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 8.  CD4(+)CD25(+) regulatory T cells as a therapeutic target in rheumatoid arthritis.

Authors:  Qing Yu; Man Xu; Fang Yu; Yong Jin
Journal:  Cent Eur J Immunol       Date:  2014-04-17       Impact factor: 2.085

Review 9.  How do regulatory T cells work?

Authors:  A Corthay
Journal:  Scand J Immunol       Date:  2009-10       Impact factor: 3.487

10.  Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?

Authors:  Bruce M Hall; Giang T Tran; Nirupama D Verma; Karren M Plain; Catherine M Robinson; Masaru Nomura; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2013-08-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.